Lecture Details - Overview

View all Online CME

Continuing Education Information

Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Molecular Profiling and Decision Making in Breast Cancer: Clinical and Molecular Prognostic Information—Addressing Discordant Results

Release Date: December 30, 2008| Expiration Date: December 30, 2009
Dec 11, 2008, Online Learning Series Program 4

Lecture Overview

Molecular Profiling and Decision Making in Breast Cancer: A Continual Online Learning Series is designed to provide sustained online learning for oncologists and other health care providers involved in the diagnosis and treatment of breast cancer. In the area of molecular profiling, the recent emergence of commercially available gene profiling tools, coupled with their variable degree of benefit balanced against the short- and long-term effects of chemotherapy, creates a pressing educational need for clinicians.

This educational activity is directed toward medical and surgical oncologists who counsel patients on therapeutic decisions following surgery for early-stage breast cancer. Other physicians, including pathologists, radiation oncologists, primary care physicians, and other health care providers, including nurses, pharmacists, and others who care for patients with breast cancer, are also invited to participate. No specific skills or knowledge other than a basic training in oncology is required for successful participation in this activity.

At the conclusion of this activity, you should be able to:

  • Discuss the molecular heterogeneity of breast cancer and the relationship of gene-based molecular profiles to clinical outcomes
  • Compare and contrast different molecular profiling assays and their ability to provide accurate prognosis of patients with early-stage breast cancer
  • Apply molecular profiling to patient decision making in defined clinical scenarios
  • Describe the advantages and limitations of different molecular profiling assays and indications for participation in clinical trials designed to further evaluate their utility in decision making for early-stage breast cancer

Instructions for Participation

  1. Read the following information before beginning the educational activity.
  2. Complete the Pretest.
  3. View and study all Flash video presentations.
  4. Complete the CME test.
  5. Answer the evaluation questions.
  6. After successful completion of the CME test and evaluation, you will receive your certificate online.

CME credit will be granted for online participation only.
Successful completion is determined by a score of 75% or greater.

View the Activity
You will be asked to login
or create an account.

Educational Grants

An educational grant for this activity was provided by:


  1. Agendia